France’s drug safety agency warned on Monday of potentially serious side effects of treatments being tested against the new coronavirus after the deaths of three people possibly linked to self-medication.
Another two dozen patients have reported undesirable side effects after taking Plaquenil – the brand name of hydroxychloroquine – as well as other medicines such as the antiretroviral Kaletra, the agency’s head Dominique Martin told AFP.
The drug safety agency (ANSM) began boosting its surveillance two weeks ago of trials of drugs against COVID-19, “in particular when they are used outside of clinical trials of chloroquine, hydroxychloroquine, azithromycin, lopinavir/ritonavir (Kaletra), tocilizumab (and) colchicine,” Martin said.
Full story at France24
Article submitted by Bogdan Sunder